ID   B3GL1_HUMAN             Reviewed;         331 AA.
AC   O75752; D3DNM4; Q3Y531; Q6IAI5; Q8NFM8; Q8NFM9; Q9HA06;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   10-MAY-2017, entry version 148.
DE   RecName: Full=UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1;
DE            Short=Beta-1,3-GalNAc-T1;
DE            EC=2.4.1.79 {ECO:0000269|PubMed:10993897};
DE   AltName: Full=Beta-1,3-galactosyltransferase 3;
DE            Short=Beta-1,3-GalTase 3;
DE            Short=Beta3Gal-T3;
DE            Short=Beta3GalT3;
DE            Short=b3Gal-T3;
DE   AltName: Full=Beta-3-Gx-T3;
DE   AltName: Full=Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase;
DE   AltName: Full=Globoside synthase;
DE   AltName: Full=UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase;
GN   Name=B3GALNT1; Synonyms=B3GALT3; ORFNames=UNQ531/PRO1074;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], COFACTOR, AND TISSUE SPECIFICITY.
RX   PubMed=9582303; DOI=10.1074/jbc.273.21.12770;
RA   Amado M., Almeida R., Carneiro F., Levery S.B., Holmes E.H.,
RA   Nomoto M., Hollingsworth M.A., Hassan H., Schwientek T., Nielsen P.A.,
RA   Bennett E.P., Clausen H.;
RT   "A family of human beta3-galactosyltransferases. Characterization of
RT   four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-N-
RT   acetyl-galactosamine beta-1,3-galactosyltransferase family.";
RL   J. Biol. Chem. 273:12770-12778(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   TISSUE SPECIFICITY, AND POLYMORPHISM.
RC   TISSUE=Kidney;
RX   PubMed=10993897; DOI=10.1074/jbc.M006902200;
RA   Okajima T., Nakamura Y., Uchikawa M., Haslam D.B., Numata S.,
RA   Furukawa K., Urano T., Furukawa K.;
RT   "Expression cloning of human globoside synthase cDNAs. Identification
RT   of beta3Gal-T3 as UDP-N-acetylgalactosamine:globotriaosylceramide
RT   beta1,3-N-acetylgalactosaminyltransferase.";
RL   J. Biol. Chem. 275:40498-40503(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Luo W.Q., Chen J.H., Huang X.W., Zhou Y., Zhou H.J., Hu S.N.,
RA   Yuan J.G.;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zhou H.J., Huang X.W., Zhou Y., Hu S.L., Yuan J.G., Qiang B.Q.;
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ALA-266 AND ARG-271, AND
RP   POLYMORPHISM.
RX   PubMed=12023287; DOI=10.1074/jbc.M203047200;
RA   Hellberg A., Poole J., Olsson M.L.;
RT   "Molecular basis of the globoside-deficient P(k) blood group
RT   phenotype. Identification of four inactivating mutations in the UDP-N-
RT   acetylgalactosamine: globotriaosylceramide 3-beta-N-
RT   acetylgalactosaminyltransferase gene.";
RL   J. Biol. Chem. 277:29455-29459(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-126.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH47618.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transfers N-acetylgalactosamine onto
CC       globotriaosylceramide. {ECO:0000269|PubMed:10993897}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine + alpha-D-
CC       galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-
CC       (1<->1)-ceramide = UDP + N-acetyl-beta-D-galactosaminyl-(1->3)-
CC       alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-
CC       glucosyl-(1<->1)-ceramide. {ECO:0000269|PubMed:10993897}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10993897,
CC         ECO:0000269|PubMed:9582303};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type
CC       II membrane protein.
CC   -!- TISSUE SPECIFICITY: Higher expression in heart and brain, and to a
CC       lesser extent in lung, placenta, kidney and testis. Lower
CC       expression in liver, spleen and stomach. No expression in skeletal
CC       muscle. {ECO:0000269|PubMed:10993897, ECO:0000269|PubMed:9582303}.
CC   -!- POLYMORPHISM: Genetic variation in B3GALNT1 is responsible for the
CC       blood group P1PK system [MIM:111400]. Different combinations or
CC       absence of the P1PK antigens define 5 different phenotypes: P1,
CC       P2, P1(k), P2(k), and P. The P1(k) and P2(k) phenotypes are rare
CC       and characterized by lack of the P antigen.
CC       {ECO:0000269|PubMed:12023287}.
CC   -!- POLYMORPHISM: B3GALNT1 activity is responsible for the globoside
CC       blood group system (GLOB), which is defined by the P antigen
CC       [MIM:615021]. {ECO:0000269|PubMed:10993897}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 31 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=dbRBC/BGMUT; Note=Blood group antigen gene
CC       mutation database;
CC       URL="https://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi.cgi?cmd=bgmut/systems_info&system=p";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/b3galt3/";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Beta-1,3-galactosyltransferase 3;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_451";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y15062; CAA75346.1; -; mRNA.
DR   EMBL; AB050855; BAB17690.1; -; mRNA.
DR   EMBL; AB050856; BAB17691.1; -; mRNA.
DR   EMBL; AF132731; AAF66442.1; -; mRNA.
DR   EMBL; AF154848; AAF72106.1; -; mRNA.
DR   EMBL; AF494105; AAM96011.1; -; Genomic_DNA.
DR   EMBL; AF494106; AAM96012.1; -; Genomic_DNA.
DR   EMBL; AY359049; AAQ89408.1; -; mRNA.
DR   EMBL; CR457170; CAG33451.1; -; mRNA.
DR   EMBL; DQ158095; AAZ67917.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78621.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78623.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78624.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78625.1; -; Genomic_DNA.
DR   EMBL; BC047618; AAH47618.1; -; mRNA.
DR   CCDS; CCDS3193.1; -.
DR   RefSeq; NP_001033717.1; NM_001038628.1.
DR   RefSeq; NP_003772.1; NM_003781.3.
DR   RefSeq; NP_149357.1; NM_033167.2.
DR   RefSeq; NP_149358.1; NM_033168.2.
DR   RefSeq; NP_149359.1; NM_033169.2.
DR   RefSeq; XP_005247916.1; XM_005247859.4.
DR   UniGene; Hs.418062; -.
DR   UniGene; Hs.606694; -.
DR   ProteinModelPortal; O75752; -.
DR   BioGrid; 114249; 26.
DR   IntAct; O75752; 1.
DR   STRING; 9606.ENSP00000323479; -.
DR   SwissLipids; SLP:000000789; -.
DR   CAZy; GT31; Glycosyltransferase Family 31.
DR   iPTMnet; O75752; -.
DR   PhosphoSitePlus; O75752; -.
DR   BioMuta; B3GALNT1; -.
DR   EPD; O75752; -.
DR   MaxQB; O75752; -.
DR   PaxDb; O75752; -.
DR   PeptideAtlas; O75752; -.
DR   PRIDE; O75752; -.
DR   DNASU; 8706; -.
DR   Ensembl; ENST00000320474; ENSP00000323479; ENSG00000169255.
DR   Ensembl; ENST00000392779; ENSP00000376530; ENSG00000169255.
DR   Ensembl; ENST00000392781; ENSP00000376532; ENSG00000169255.
DR   Ensembl; ENST00000473285; ENSP00000418226; ENSG00000169255.
DR   Ensembl; ENST00000488170; ENSP00000420163; ENSG00000169255.
DR   GeneID; 8706; -.
DR   KEGG; hsa:8706; -.
DR   UCSC; uc003fdv.4; human.
DR   CTD; 8706; -.
DR   DisGeNET; 8706; -.
DR   GeneCards; B3GALNT1; -.
DR   HGNC; HGNC:918; B3GALNT1.
DR   HPA; HPA041204; -.
DR   MIM; 111400; phenotype.
DR   MIM; 603094; gene.
DR   MIM; 615021; phenotype.
DR   neXtProt; NX_O75752; -.
DR   OpenTargets; ENSG00000169255; -.
DR   PharmGKB; PA25211; -.
DR   eggNOG; KOG2287; Eukaryota.
DR   eggNOG; ENOG410ZZ1B; LUCA.
DR   GeneTree; ENSGT00760000118879; -.
DR   HOGENOM; HOG000059604; -.
DR   HOVERGEN; HBG101817; -.
DR   InParanoid; O75752; -.
DR   KO; K00719; -.
DR   OMA; RFTLREH; -.
DR   OrthoDB; EOG091G0AXM; -.
DR   PhylomeDB; O75752; -.
DR   TreeFam; TF318639; -.
DR   BRENDA; 2.4.1.122; 2681.
DR   BRENDA; 2.4.1.62; 2681.
DR   BRENDA; 2.4.1.79; 2681.
DR   BRENDA; 2.4.1.88; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; B3GALNT1; human.
DR   GeneWiki; B3GALNT1; -.
DR   GenomeRNAi; 8706; -.
DR   PRO; PR:O75752; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000169255; -.
DR   CleanEx; HS_B3GALNT1; -.
DR   ExpressionAtlas; O75752; baseline and differential.
DR   Genevisible; O75752; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0047273; F:galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity; TAS:Reactome.
DR   GO; GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; TAS:ProtInc.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0009312; P:oligosaccharide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006486; P:protein glycosylation; TAS:ProtInc.
DR   InterPro; IPR002659; Glyco_trans_31.
DR   PANTHER; PTHR11214; PTHR11214; 1.
DR   Pfam; PF01762; Galactosyl_T; 1.
PE   1: Evidence at protein level;
KW   Blood group antigen; Complete proteome; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Magnesium; Membrane;
KW   Polymorphism; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    331       UDP-GalNAc:beta-1,3-N-
FT                                acetylgalactosaminyltransferase 1.
FT                                /FTId=PRO_0000219153.
FT   TOPO_DOM      1     20       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     21     43       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     44    331       Lumenal. {ECO:0000255}.
FT   CARBOHYD     72     72       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    154    154       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    198    198       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    326    326       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     126    126       D -> N (in dbSNP:rs2231257).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_025091.
FT   VARIANT     266    266       E -> A (associated with P2(k) phenotype;
FT                                dbSNP:rs28937582).
FT                                {ECO:0000269|PubMed:12023287}.
FT                                /FTId=VAR_019646.
FT   VARIANT     271    271       G -> R (associated with P1(k) phenotype;
FT                                dbSNP:rs104893683).
FT                                {ECO:0000269|PubMed:12023287}.
FT                                /FTId=VAR_019647.
SQ   SEQUENCE   331 AA;  39512 MW;  3556BCAF1646F702 CRC64;
     MASALWTVLP SRMSLRSLKW SLLLLSLLSF FVMWYLSLPH YNVIERVNWM YFYEYEPIYR
     QDFHFTLREH SNCSHQNPFL VILVTSHPSD VKARQAIRVT WGEKKSWWGY EVLTFFLLGQ
     EAEKEDKMLA LSLEDEHLLY GDIIRQDFLD TYNNLTLKTI MAFRWVTEFC PNAKYVMKTD
     TDVFINTGNL VKYLLNLNHS EKFFTGYPLI DNYSYRGFYQ KTHISYQEYP FKVFPPYCSG
     LGYIMSRDLV PRIYEMMGHV KPIKFEDVYV GICLNLLKVN IHIPEDTNLF FLYRIHLDVC
     QLRRVIAAHG FSSKEIITFW QVMLRNTTCH Y
//
